Hjem › Diffust intrinsisk pontin gliom › Ohio
Diffust intrinsisk pontin gliom kliniske forsøg i Ohio
12 studier for Diffust intrinsisk pontin gliom søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 21. sep. 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
12 Months – 21 Years · Alle køn · Opdateret 11. sep. 2026 · NCT04870944Targeted Pediatric High-Grade Glioma Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererObservationsstudie
12 Months – 39 Years · Alle køn · Opdateret 8. sep. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 1. sep. 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
Alder 1 til 26 · Alle køn · Opdateret 4. aug. 2026 · NCT07680439Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 1/2
Alder 4 til 39 · Alle køn · Opdateret 20. jul. 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
Alder 1 til 21 · Alle køn · Opdateret 29. jun. 2026 · NCT06333899Combination Therapy for the Treatment of Diffuse Midline Gliomas
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
Alder 2 til 39 · Alle køn · Opdateret 26. jun. 2026 · NCT05009992Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 29. maj 2026 · NCT05843253A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererTidlig fase 1
Op til 21 år · Alle køn · Opdateret 18. mar. 2026 · NCT04655404International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 20. okt. 2025 · NCT03101813Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.